Wockhardt slipped 3.66% to Rs 90.75 at 13:03 IST on BSE, on reports US drug major Eli Lilly has sued the company for patent infringement on antidepressant drug.
The stock hit a high of Rs 93 so far during the day. The stock hit a low of Rs 89 so far during the day, which is record low for the counter. The stock has a 52-week high of Rs 448 on 17 December 2007.
The company's current equity is Rs 54.72 crore. Face value per share is Rs 5.
The current price of Rs 90.75 discounts the company's Q3 September 2008 annualized EPS of Rs 4.91, by a PE multiple of 18.48.
As per reports, Eli Lilly and Co has sued Wockhardt in the US Federal court after the later filed abbreviated new drug applications (ANDA) with US Food & Drug Administration (USFDA) to manufacture and market Lilly's blockbuster drug, Cymbalta.
Wockhardt's net profit fell 77.2% to Rs 13.43 crore on 20.9% increase in net sales to Rs 416.83 crore in Q3 September 2008 over Q3 September 2007.
Wockhardt has presence in different drug segments like inflammation and pain, anti-infective, cough syrups, corticosteroids and medical nutrition.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment